In vitro and in vivo characterization of Entacapone-loaded nanostructured lipid carriers developed by quality-by-design approach

• 主要な著者: Yogeeta Agrawal (著者), Kiran Patil (著者), Hitendra Mahajan (著者), Mrugendra Potdar (著者), Pratiksha Joshi (著者), Kartik Nakhate (著者), Charu Sharma (著者), Sameer N. Goyal (著者), Shreesh Ojha (著者)
• フォーマット: 図書
• 出版事項: Taylor & Francis Group, 2022-12-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Entacapone, a reversible catechol-o-methyl transferase inhibitor, is used to enhance the action of dopamine agonists by reducing their metabolism and the 'Wearing-off' effects associated with long-term use in the treatment of Parkinson's disease. It is used as an adjunct to levodopa/C...